Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...
When it comes to successfully completing clinical studies, keeping patients enrolled is crucial. Lengthy trials pose a significant risk of patients dropping out, especially if invasive procedures are ...
In addition to improving payment speed, accuracy, and transparency, modern payment technology is creating new opportunities to further improve the trial experience. For example, AI is being used to ...
This study was a convergent parallel mixed-methods design, using a survey for quantitative analysis and focus group discussions (FGDs) for further qualitative investigation. The health care providers ...
WALNUT CREEK, Calif. & FARGO, N.D.--(BUSINESS WIRE)--Hawthorne Health, the leader in community trial delivery, and RxE2, a pioneer in pharmacist-led clinical trial services, have announced a strategic ...
Avik Pal, Founder and CEO of CliniOps, a technology and data company with multiple patents to digitize global clinical trials. When Michael J. Fox and Stephen Hawking publicly shared their personal ...
Hosted on MSN
Patient-centric trials: progress but gaps remain
Patient-centricity has become a buzzword in recent years, with companies touting more inclusive trial designs and bringing patients and advocates into early planning stages. On Clinical Trials Day ...
At the SCOPE Summit, Tekton Research shares how its physician-led clinical trial network is helping accelerate research in neuroscience and cardiometabolic disease. By pairing pra ...
DEERFIELD, Ill.--(BUSINESS WIRE)--With a history of more than 120 years serving communities across the country, Walgreens prides itself in being a trusted retail pharmacy partner for more than 9 ...
The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive trial designs may ...
Decentralized Clinical Trials Market OverviewThe global decentralized clinical trials (DCTs) market is witnessing strong momentum and is valued at approximately USD 8.8 billion in 2025, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results